Rosiglitazone RECORD study: glucose control outcomes at 18 months

AIMS: To compare glucose control over 18 months between rosiglitazone oral combination therapy and combination metformin and sulphonylurea in people with Type 2 diabetes. METHODS: RECORD, a multicentre, parallel-group study of cardiovascular outcomes, enrolled people with an HbA(1c) of 7.1–9.0% on m...

Descripción completa

Detalles Bibliográficos
Autores principales: Home, P D, Jones, N P, Pocock, S J, Beck-Nielsen, H, Gomis, R, Hanefeld, M, Komajda, M, Curtis, P
Formato: Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2007
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1974811/
https://www.ncbi.nlm.nih.gov/pubmed/17517066
http://dx.doi.org/10.1111/j.1464-5491.2007.02160.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1974811/
https://www.ncbi.nlm.nih.gov/pubmed/17517066
http://dx.doi.org/10.1111/j.1464-5491.2007.02160.x

Ejemplares similares